Private Equity Bigwigs Buy Biomet

Dec 20 2006 | 11:42am ET

A consortium of private equity heavyweights has agreed to pay $10.9 billion for medical device manufacturer Biomet.

The group includes the Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts and Texas Pacific Group.

Warsaw, Ind.-based Biomet designs and manufactures musculoskeletal medical products. The deal, which offers $44 per share and was unanimously approved by Biomet’s board, awaits shareholder approval.


In Depth

GSAM's Papagiannis: Liquid Alternatives For The Long Run

Apr 21 2017 | 8:44pm ET

Interest in liquid alternatives cooled a bit last year amid a broad shift in investor...

Lifestyle

Aston Martin Returns To Debt Market As DB11 Drives Turnaround

Mar 31 2017 | 5:21pm ET

James Bond’s preferred carmaker is returning to the public debt markets for the...

Guest Contributor

Debunking Conventional Investment Wisdom (Part II)

Apr 17 2017 | 5:56pm ET

The alternative investment industry is currently replete with buzzwords around data...

 

From the current issue of